Ray Co., Ltd. (KOSDAQ:228670)
South Korea · Delayed Price · Currency is KRW 7,020.00
+30.00 (0.43%)
Aug 14, 2025, 3:30 PM KST
Ray Co., Ltd. Market Cap
Ray Co., Ltd. has a market cap or net worth of 109.53 billion as of August 15, 2025. Its market cap has decreased by -42.48% in one year.
Market Cap
109.53B
Enterprise Value
166.93B
Revenue
86.94B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,020.00
Market Cap Chart
Since August 8, 2019, Ray Co., Ltd.'s market cap has decreased from 164.67B to 109.53B, a decrease of -33.49%. That is a compound annual growth rate of -6.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 109.53B | 21.31% |
| Dec 30, 2024 | 90.29B | -74.15% |
| Dec 28, 2023 | 349.24B | 7.23% |
| Dec 29, 2022 | 325.68B | -13.67% |
| Dec 30, 2021 | 377.24B | 6.38% |
| Dec 30, 2020 | 354.62B | 24.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.58T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,561.74B |
| Peptron | 8,235.61B |
| SK Biopharmaceuticals | 7,878.31B |
| PharmaResearch | 7,106.52B |
| LigaChem Biosciences | 5,666.20B |